4.7 Article

Metabolic Remodeling with Hepatosteatosis Induced Vascular Oxidative Stress in Hepatic ERK2 Deficiency Mice with High Fat Diets

Related references

Note: Only part of the references are listed.
Review Gastroenterology & Hepatology

A Meta-Analysis on the Global Prevalence, Risk factors and Screening of Coronary Heart Disease in Nonalcoholic Fatty Liver Disease

Jonathan Zhi Kai Toh et al.

Summary: This study aims to explore the association between coronary heart disease (CHD) and nonalcoholic fatty liver disease (NAFLD) by investigating the global prevalence, independent risk factors, and influence of steatosis grade on manifestation of CHD among patients with NAFLD.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Cell Biology

Sarco/Endoplasmic Reticulum Ca2+ ATPase 2 Activator Ameliorates Endothelial Dysfunction; Insulin Resistance in Diabetic Mice

Toyokazu Kimura et al.

Summary: This study found that SERCA2 protein expression decreased in the aorta of diabetic mice, and CDN1163 improved aortic endothelial dysfunction, glucose tolerance, hepatosteatosis, and skeletal muscle function in these mice.

CELLS (2022)

Article Cell Biology

Adipose tissue inflammation and metabolic dysfunction in obesity

Tatsuo Kawai et al.

Summary: Chronic low-grade inflammation of adipose tissue is linked to metabolic disease and organ complications, mainly caused by the secretion of inflammatory substances by adipocytes and infiltration of immune cells. Despite being low-grade, this inflammation negatively impacts remote organ function and is considered a causative factor of obesity-related complications.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2021)

Review Cardiac & Cardiovascular Systems

Non-alcoholic fatty liver disease and heart failure with preserved ejection fraction: from pathophysiology to practical issues

Romain Itier et al.

Summary: The prevalence of NAFLD in HFpEF patients can reach 50%, with a growing evidence linking NAFLD to increased incidence of cardiovascular diseases. NAFLD and HFpEF share common risk factors and cardiac outcomes, indicating a pathophysiological continuum between the two conditions.

ESC HEART FAILURE (2021)

Review Medicine, General & Internal

Interplay between Heart Disease and Metabolic Steatosis: A Contemporary Perspective

Mohammad Said Ramadan et al.

Summary: The liver-heart axis is a field of growing interest due to increasing evidence of complex bidirectional interplay between the two organs. NAFLD has a significant association with a wide spectrum of structural and functional cardiac diseases, while the impact of cardiac disease on NAFLD is not well studied. Further investigation into the heart-liver relationship is warranted due to the global health and economic burden posed by both diseases.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Endocrinology & Metabolism

Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk

Emir Muzurovic et al.

Summary: NAFLD is closely related to insulin resistance, metabolic syndrome, and cardiovascular disease risk, but its independent impact on the development of cardiovascular disease remains controversial.

METABOLISM-CLINICAL AND EXPERIMENTAL (2021)

Article Biochemistry & Molecular Biology

Arachidonic Acid as an Early Indicator of Inflammation during Non-Alcoholic Fatty Liver Disease Development

Klaudia Sztolsztener et al.

BIOMOLECULES (2020)

Review Medicine, General & Internal

Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis- Literature Review

Abdulrahman Ismaiel et al.

FRONTIERS IN MEDICINE (2019)

Review Medicine, Research & Experimental

Skeletal muscle inflammation and insulin resistance in obesity

Huaizhu Wu et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Review Endocrinology & Metabolism

Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: A systematic review and meta-analysis

Toufik Mahfood Haddad et al.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2017)

Review Cell Biology

Adiponectin Receptor as a Key Player in Healthy Longevity and Obesity-Related Diseases

Toshimasa Yamauchi et al.

CELL METABOLISM (2013)

Article Cardiac & Cardiovascular Systems

Hepatic Extracellular Signal-Regulated Kinase 2 Suppresses Endoplasmic Reticulum Stress and Protects From Oxidative Stress and Endothelial Dysfunction

Takehiko Kujiraoka et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)

Article Hematology

Tissue-Specific Insulin Signaling, Metabolic Syndrome, and Cardiovascular Disease

Christian Rask-Madsen et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)

Review Cardiac & Cardiovascular Systems

Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?

Lokpal S. Bhatia et al.

EUROPEAN HEART JOURNAL (2012)

Article Neurosciences

ERK2 Contributes to the Control of Social Behaviors in Mice

Yasushi Satoh et al.

JOURNAL OF NEUROSCIENCE (2011)

Article Cardiac & Cardiovascular Systems

Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community

Rainer H. Boeger et al.

CIRCULATION (2009)

Article Cardiac & Cardiovascular Systems

Diminished Global Arginine Bioavailability and Increased Arginine Catabolism as Metabolic Profile of Increased Cardiovascular Risk

W. H. Wilson Tang et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)

Editorial Material Cell Biology

Selective versus total insulin resistance: A pathogenic paradox

Michael S. Brown et al.

CELL METABOLISM (2008)